Deletion of wboA enhances activation of the lectin pathway of complement in Brucella abortus and Brucella melitensis

Infection and Immunity

Volumn 69, Issue 7, 2001, Pages 4407-4416

  Fernandez Prada, C M ^a   Nikolich, M ^a   Vemulapalli, R ^a   Sriranganathan, N ^a   Boyle, S M ^a   Schurig, G G ^a   Hadfield, T L ^a   Hoover, D L ^a  

^a WALTER REED ARMY INSTITUTE OF RESEARCH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL POLYSACCHARIDE; COMPLEMENT; COMPLEMENT COMPONENT C1Q; COMPLEMENT COMPONENT C2; COMPLEMENT COMPONENT C3B; COMPLEMENT MEMBRANE ATTACK COMPLEX; EGTAZIC ACID; GLYCOSYLTRANSFERASE; LECTIN; MAGNESIUM DERIVATIVE; MANNOSE BINDING PROTEIN; PROTEIN WBOA; UNCLASSIFIED DRUG;

ARTICLE; BACTERIAL GENE; BACTERIAL VIRULENCE; BRUCELLA ABORTUS; BRUCELLA MELITENSIS; CARBOHYDRATE SYNTHESIS; CELL SURFACE; COMPLEMENT ACTIVATION; COMPLEMENT DEPOSITION; CONTROLLED STUDY; FLOW CYTOMETRY; GENE DELETION; HUMAN; NONHUMAN; PHAGOCYTE; PRIORITY JOURNAL; SERUM BACTERICIDAL ACTIVITY;

BRUCELLA ABORTUS; BRUCELLA MELITENSIS; CARRIER PROTEINS; COLLECTINS; GLYCOSYLTRANSFERASES; HUMANS; LECTINS;

EID: 0034978969     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/IAI.69.7.4407-4416.2001     Document Type: Article

References (58)

1. Analysis of complement C3 deposition and degradation on Klebsiella pneumoniae
2. Interaction between complement subcomponent C1q and the Klebsiella pneumoniae porin OmpK36
3. Transposon-derived Brucella abortus rough mutants are attenuated and exhibit reduced intracellular survival
4. Surface exposure of outer membrane protein and lipopolysaccharide epitopes in Brucella species studied by enzyme-linked immunosorbent assay and flow cytometry
5. Outer-membrane protein- and rough lipopolysaccharide-specific monoclonal antibodies protect mice against Brucella ovis
6. Heterogeneity in the complement-dependent bacteriolysis within the species of Borrelia burgdorferi
7. The role of complement and complement receptors in induction and regulation of immunity
8. Molecular and immunological characterization of the major outer membrane proteins of Brucella
9. Killing of Brucella abortus by bovine serum
10. Induction of TNF-α in human peripheral blood mononuclear cells by the mannoprotein of Cryptococcus neoformans involves human mannose binding protein
11. Role of the YadA protein in prevention of opsonization of Yersinia enterocolitica by C3b molecules
12. Serum sensitivity of field isolates and laboratory strains of Brucella abortus
13. Mechanism of serum resistance among Brucella abortus isolates
14. Burkholderia pseudomallei activates complement and is ingested but not killed by polymorphonuclear leukocytes
15. C1q-how many functions? How many receptors?
16. The membrane attack complex of complement: Assembly, structure and cytotoxic activity
17. The interaction of Brucella melitensis 16-M and caprine polymorphonuclear leukocytes
18. A flow cytometric immunoassay to quantify adsorption of complement activation products (iC3b, C3d, SC5b-9) on artificial surfaces
19. Identification of the perosamine synthetase gene of Brucella melitensis 16M and involvement of lipopolysaccharide O side chain in Brucella survival in mice and in macrophages
20. Structural aspects of collectins and receptors for collectins
21. Complement binding to Aspergillus conidia correlates with pathogenicity
22. Inhibition of complement-mediated killing of Brucella abortus by fluid-phase immunoglobulins
23. Contradictory roles for antibody and complement in the interaction of Brucella abortus with its host
24. Collectins: Collagenous C-type lectins of the innate immune defense system
25. Target recognition failure by the nonspecific defense system: Surface constituents of pathogens interfere with the alternative pathway of complement activation
26. Activation of complement by mannose-binding lectin on isogenic mutants of Neisseria meningitidis serogroup B
27. Bactericidal but not nonbactericidal C5b-9 is associated with distinctive outer membrane proteins in Neisseria gonorrhoeae
28. Membrane changes induced by exposure of Escherichia coli to human serum
29. Genetic characterization of a Tn5-disrupted glycosyltransferase gene homolog in Brucella abortus and its effect on lipopolysaccharide composition and virulence
30. Fine structure of A and M antigens from Brucella biovars
31. Mesophilic Aeromonas sp. serogroup O:11 resistance to complement-mediated killing
32. Activation of the complement classical pathway (C1q binding) by mesophilic Aeromonas hydrophila outer membrane protein
33. Physiology and pathophysiology of complement: Progress and trends
34. Mechanism of YadA-mediated serum resistance of Yersinia enterocolitica serotype O3
35. Interaction of human mannose-binding protein with Mycobacterium avium
36. Survival of smooth, rough and transposon mutant strains of Brucella abortus in bovine mammary macrophages
37. Innate immunity
38. Helicobacter pylori urease significantly reduces opsonization by human complement
39. Pulmonary surfactant protein A modulates the cellular response to smooth and rough lipopolysaccharides by interaction with CD14
40. Biological properties of RB51: A stable rough strain of Brucella abortus
41. Brucellosis vaccines: Past, present and future
42. Interaction of human complement proteins with serum-sensitive and serum-resistant strains of Escherichia coli
43. A second serine protease associated with mannan-binding lectin that activates complement
44. Complement defense mechanisms
45. Role of sialic acid in the resistance of Trypanosoma cruzi trypomastigotes to complement
46. Mannose-binding lectin: The pluripotent molecule of the innate immune system
47. Mannose-binding lectin (MBL) in health and disease
48. Inhibition of the hemolytic activity of the first component of complement C1 by an Escherichia coli C1q binding protein
49. C-type lectins and galectins mediate innate and adaptive immune functions: Their roles in the complement activation pathway
50. Identification of an IS711 element interrupting the wboA gene of Brucella abortus vaccine strain RB51 and a PCR assay to distinguish strain RB51 from other Brucella species and strains
51. Complementation of Brucella abortus RB51 with a functional wboA gene results in O-antigen synthesis and enhanced vaccine efficacy but no change in rough phenotype and attenuation
52. Brucella a monospecific genus as shown by deoxyribonucleic acid hybridization
53. DNA polymorphism at the omp-31 locus of Brucella spp.: Evidence for a large deletion in Brucella abortus, and other species-specific markers
54. Molecular characterization of a Brucella species large DNA fragment deleted in Brucella abortus strains: Evidence for a locus involved in the synthesis of a polysaccharide
55. Protection of BALB/c mice against homologous and heterologous species of Brucella by rough strain vaccines derived from Brucella melitensis and Brucella suis biovar 4
56. Evasion of pathogens by avoiding recognition or eradication by complement, in part via molecular mimicry
57. Human brucellosis
58. Phagocytosis and killing of Brucella by human polymorphonuclear leukocytes